PKM and osteosarcoma: Furthermore, LINC00689 also was recently reported to be involved in osteosarcoma progression via the miR-655/SOC18 axis (Xing et al., 2020) and growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis (Liu et al., 2019).